Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple

Yuki Kimura1, Nina Jones, Michael Klüppel

  • 1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, Canada M5G 1X5.

Insights

Mutations in the Kit receptor tyrosine kinase

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The murine dominant white spotting/c-kit locus is vital for numerous biological processes.
  • Loss-of-function mutations lead to diverse phenotypes, including anemia, pigmentation defects, and neurological deficits.

Purpose of the Study:

  • To investigate the specific roles of tyrosine residues 567 and 569 in the juxtamembrane (Jx) domain of the murine Kit receptor tyrosine kinase.
  • To elucidate the cell-type specific functions of the Kit receptor's Jx domain in vivo.

Main Methods:

  • Generation and analysis of mice with specific mutations in Kit receptor tyrosine residues.
  • Assessment of Kit receptor signaling pathways, including autophosphorylation and downstream kinase activation (ERK/MAPK).
  • Phenotypic analysis of mutant mice, evaluating cell lineage development and organ morphology.

Main Results:

  • Tyrosine residues 567 and 569 in the Kit Jx domain are essential for melanogenesis and mast cell development.
  • These tyrosines are dispensable for erythroid, interstitial cells of Cajal, and germ cell development.
  • Mutant mice exhibit splenomegaly, B-cell and megakaryocyte dysregulation, and enlarged stomachs.
  • Jx tyrosine mutations reduce Kit receptor autophosphorylation and selectively impair ERK/MAPK activation.

Conclusions:

  • The juxtamembrane domain of the Kit receptor tyrosine kinase plays a cell-type specific regulatory role.
  • Engineered Kit mutations can dissect the complex signaling events downstream of receptor tyrosine kinases.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: